Clicky

T2 Biosystems, Inc.(TTOO)

Description: T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products based on its proprietary platform. Its T2 Magnetic Resonance platform enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, and urine. The company offers T2Dx, a bench-top instrument, which has completed a pivotal clinical trial for performing diagnostic tests in sepsis and other applications; and T2Stat, an integrated instrument for hemostasis applications. It is also developing T2Candida panel that has completed a pivotal clinical trial for identifying pathogens associated with sepsis; T2HemoStat panel, which includes a set of hemostasis measurements, including platelet function, clotting time, and clot degradation; and T2Bacteria, a multiplex diagnostic panel that detects the bacterial pathogens associated with sepsis. T2 Biosystems, Inc. was founded in 2006 and is headquartered in Lexington, Massachusetts.


Keywords: Medicine Cell Biology Diagnostic Products Biomarkers Diagnostic Tests Blood In Vitro Multiplex Intensive Care Medicine Magnetic Resonance Sepsis In Vitro Diagnostics Coagulation Coagulation System Blood Plasma Platelet Hemostasis Pivotal Whole Blood

Home Page: www.t2biosystems.com

TTOO Technical Analysis

101 Hartwell Avenue
Lexington, MA 02421
United States
Phone: 781 761 4646


Officers

Name Title
Mr. John J. Sperzel III, B.Sc. Pres, CEO & Chairman
Mr. Michael Terrence Gibbs Esq. Sr. VP & Gen. Counsel
Mr. Alec J. Barclay Sr. VP
Mr. John M. Sprague CPA Chief Financial Officer
Ms. Kelley J. Morgan Chief People Officer
Dr. Aparna Jha Ahuja M.D. Chief Medical Officer & Chairman of Scientific Advisory Board
Mr. Brett A. Giffin Chief Commercial Officer
Dr. Roger Smith Ph.D. Sr. VP of Science R&D

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 14.5044
Price-to-Sales TTM: 0.3967
IPO Date: 2014-08-07
Fiscal Year End: December
Full Time Employees: 182
Back to stocks